| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |